Neil Kaplowitz – 19 January 2005

Naga Chalasani, Cosme Manzarbeitia, Peter Ferenci, Wolfgang Vogel, Robert J. Fontana, Michael Voigt, Caroline Riely, Paul Martin, Lewis Teperman, James Jiao, Juan Carlos Lopez‐Talavera – 19 January 2005 – There is currently no effective treatment for recurrent hepatitis C after orthotopic liver transplantation (OLT). We therefore performed two randomized, controlled trials—a prophylaxis trial and a treatment trial—to evaluate the safety and efficacy of peginterferon alfa‐2a in patients who had undergone OLT.

Mario Chojkier – 19 January 2005

Ronald J. Sokol, Cara L. Mack – 19 January 2005

Blair U. Bradford, Hiroshi Kono, Fuyumi Isayama, Oksana Kosyk, Michael D. Wheeler, Taro E. Akiyama, Lisa Bleye, Kristopher W. Krausz, Frank J. Gonzalez, Dennis R. Koop, Ivan Rusyn – 19 January 2005 – The occurrence of malignant tumors of the upper gastrointestinal tract and liver is, based largely on epidemiological evidence, causally related to the consumption of ethanol. It is widely recognized that oxidants play a key role in alcohol‐induced liver injury; however, it is unclear how oxidants may be involved in DNA damage.

Eduardo Schiffer, Chantal Housset, Wulfran Cacheux, Dominique Wendum, Christèle Desbois‐Mouthon, Colette Rey, François Clergue, Raoul Poupon, Véronique Barbu, Olivier Rosmorduc – 19 January 2005 – Epidermal growth factor receptor (EGFR) binds transforming growth factor α (TGF‐α) which is mitogenic for hepatocytes. Diverse lines of evidence suggest that activation of the TGF‐α /EGFR pathway contributes to hepatocellular carcinoma (HCC) formation.

Tom Luedde, Frank Tacke, Michael P. Manns, Christian Trautwein – 19 January 2005

Uwe J. F. Tietge, Hartmut H.‐J. Schmidt, Tatjana Schütz, Patrizia Dippe, Herbert Lochs, Matthias Pirlich – 19 January 2005

Adrian Reuben – 19 January 2005

Alexander L. Gerbes, Veit Gülberg – 23 December 2004